Please login to the form below

Not currently logged in
Email:
Password:

sotagliflozin

This page shows the latest sotagliflozin news and features for those working in and with pharma, biotech and healthcare.

Sanofi and Lexicon collaborate on new medication for diabetes

Sanofi and Lexicon collaborate on new medication for diabetes

Sanofi and Lexicon Pharmaceuticals have agreed to collaborate in the development and commercialisation of sotagliflozin, an investigational new drug for diabetes. ... No increase in hypoglycaemic events was seen with sotagliflozin compared to background

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Latest Intelligence

  • Deal Watch November 2015 Deal Watch November 2015

    Staying with diabetes, so strategically important, Sanofi put in place a collaboration with Lexicon Pharmaceuticals for sotagliflozin (LX4211), an oral treatment for type 1 and type 2 diabetes. ... 2, 075. Lexicon Pharmaceuticals. Sanofi. Collaboration,

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
CAN advertising

Brief us and you’ll soon see we really CAN do it all. We’re different to other agencies. You’ll get expert...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics